MarketCap
Facebook
X
TelegramQuarterly report 2022-Q3
added 05-16-2026
Concert Pharmaceuticals PEG Ratio 2011-2026 | CNCE
Annual PEG Ratio Concert Pharmaceuticals
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.0414 | 0.173 | 0.131 | 0.161 | 0.593 | 0.013 | 0.0851 | 0.0152 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 0.593 | -0.0414 | 0.141 |
PEG Ratio of other stocks in the Biotechnology industry
| Issuer | PEG Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
FSD Pharma
HUGE
|
0.0115 | - | 5743.5 % | $ 69.7 M |  Canada |
 |
MorphoSys AG
MOR
|
-0.169 | - | 2.43 % | $ 254 M |  Germany |
 |
Happiness Biotech Group Limited
HAPP
|
-0.156 | - | 1.35 % | $ 17.8 M |  China |
 |
AgeX Therapeutics
AGE
|
0.000009 | - | -10.17 % | $ 12.2 K |  USA |
 |
Coherus BioSciences
CHRS
|
-0.0207 | $ 1.69 | 2.74 % | $ 198 M | USA |
 |
I-Mab
IMAB
|
-0.75 | - | - | $ 866 M | China |
 |
Celldex Therapeutics
CLDX
|
1.27 | $ 31.56 | 2.29 % | $ 2.1 B | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
-0.747 | - | - | $ 40.3 B | USA |
 |
Genfit SA
GNFT
|
-0.0281 | - | 2.54 % | $ 160 B |  France |
 |
BioNTech SE
BNTX
|
0.00586 | $ 93.5 | 1.35 % | $ 22.6 B | Germany |
 |
CRISPR Therapeutics AG
CRSP
|
0.0973 | $ 53.73 | 4.15 % | $ 4.83 B |  Schweiz |
 |
AstraZeneca PLC
AZN
|
0.103 | - | - | $ 96.9 B |  Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
0.254 | - | -1.52 % | $ 24.7 M | USA |
 |
Athira Pharma
ATHA
|
0.0276 | - | - | $ 269 M | USA |
 |
BiondVax Pharmaceuticals Ltd.
BVXV
|
1.57 | - | 0.74 % | $ 768 M |  Israel |
 |
Compugen Ltd.
CGEN
|
-0.077 | $ 2.74 | 3.46 % | $ 256 M | Israel |
 |
Galera Therapeutics
GRTX
|
0.0195 | - | -32.59 % | $ 7.61 M | USA |
 |
Midatech Pharma plc
MTP
|
-0.73 | - | -18.52 % | $ 27.3 M | Britain |
|
Enlivex Therapeutics Ltd.
ENLV
|
-0.041 | $ 0.76 | 11.14 % | $ 34.7 M | Israel |
 |
Esperion Therapeutics
ESPR
|
0.799 | $ 3.13 | 0.32 % | $ 651 M | USA |
 |
Eton Pharmaceuticals
ETON
|
-0.83 | $ 32.33 | 3.32 % | $ 870 M | USA |
 |
Affimed N.V.
AFMD
|
3.06 | - | -34.95 % | $ 21.5 M | Germany |
|
Forte Biosciences
FBRX
|
-0.00934 | $ 21.58 | -1.64 % | $ 279 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
-2.8 | - | - | - |  Russia |
 |
Checkmate Pharmaceuticals
CMPI
|
0.189 | - | - | $ 231 M | USA |
 |
Celyad Oncology SA
CYAD
|
0.0181 | - | - | $ 12.5 M |  Belgium |
 |
Berkeley Lights
BLI
|
0.863 | - | -7.31 % | $ 87 M | USA |
 |
Galectin Therapeutics
GALT
|
-14.3 | $ 2.71 | -2.87 % | $ 173 M | USA |
 |
Generation Bio Co.
GBIO
|
-0.476 | - | - | $ 344 M | USA |
 |
IMV
IMV
|
-0.283 | - | - | $ 13.1 M | Canada |
 |
Akero Therapeutics
AKRO
|
-1.49 | - | - | $ 3.67 B | USA |
 |
Akouos
AKUS
|
0.105 | - | 0.23 % | $ 488 M | USA |
 |
Grifols, S.A.
GRFS
|
-0.048 | $ 8.05 | 0.44 % | $ 5.47 B |  Spain |
 |
Ayala Pharmaceuticals
AYLA
|
0.0783 | - | - | $ 7.46 M | Israel |
 |
Hutchison China MediTech Limited
HCM
|
-0.44 | $ 11.68 | -0.6 % | $ 10 B | China |
 |
Heron Therapeutics
HRTX
|
-0.000567 | $ 0.91 | 3.18 % | $ 152 M | USA |
 |
Freeline Therapeutics Holdings plc
FRLN
|
-0.0155 | - | - | $ 384 M | Britain |
 |
ImmuCell Corporation
ICCC
|
0.153 | $ 10.49 | -0.1 % | $ 94.7 M | USA |
 |
Gracell Biotechnologies
GRCL
|
-0.448 | - | - | $ 3.37 B | China |
 |
Anika Therapeutics
ANIK
|
0.147 | $ 14.72 | -1.12 % | $ 211 M | USA |
 |
Advaxis
ADXS
|
-0.00008 | - | -9.65 % | $ 45.9 M | USA |
 |
Aeterna Zentaris
AEZS
|
0.00152 | - | 5.93 % | $ 314 M | Canada |
 |
Aeglea BioTherapeutics
AGLE
|
-0.0134 | - | - | $ 1.01 B | USA |
 |
CureVac N.V.
CVAC
|
4.05 | - | - | $ 867 M | Germany |
 |
Applied Genetic Technologies Corporation
AGTC
|
-0.0406 | - | - | $ 26.5 M | USA |
 |
AIkido Pharma
AIKI
|
-0.000778 | - | 1.93 % | $ 17.4 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-0.000013 | $ 3.35 | -2.62 % | $ 5.51 M | Israel |